Showing results (371-380 of 572) with videos related to

Sort By:
Pageof 58
The Lancet. Oncology|June 29, 2026
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trialGiulio Francolini, Vanessa Di Cataldo, Saverio Caini, et al.
Investigational New Drugs|March 5, 2025
First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphomaMelissa Johnson, David Hong, Irene Braña, et al.
Cancer|August 25, 2005
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinomaDavid Hong, Simon Lunagomez, E Edmund Kim, et al.
Journal of Cancer|February 18, 2011
Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid TumorsAung Naing, James M Reuben, Luis H Camacho, et al.
Cancer|June 22, 2010
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Siqing Fu, Chaan Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapyCorbin Jacobs, Vasu Tumati, Payal Kapur, et al.
Korean Circulation Journal|July 8, 2025
Association Between Vasoactive Inotropic Score and Clinical Outcomes in Patients With Fulminant MyocarditisDavid Hong, Minjung Bak, Hyukjin Park, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 11, 2024
Novel Risk Scoring Model to Predict the Implementation of Veno-Arterial Extracorporeal Membrane Oxygenation in Patients With Acute MyocarditisDavid Hong, Minjung Bak, Hyukjin Park, et al.
The Journal of Urology|August 25, 2022
Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness StudyBrian De, Dario Pasalic, Daniel A Barocas, et al.
European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.
Pageof 58